Product Information

CARVEDILOL ER 40 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $6.4442 per EA under NDC 00115125008. Its NADAC has been published 124 times since Apr 10, 2024.

FDA first approved this application on May 7, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL ER 40 MG CAPSULE

CARVEDILOL PHOSPHATE
$6.4442per EA

Strength

40 mg/1

NDC

00115125008

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARVEDILOL PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204717

FDA Approved

5/7/2018

TE Code

AB

On Market Since

1/1/2024

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL ER 40 MG CAPSULE has been published 124 times since Apr 10, 2024, and over the history we have for it it has risen 23.5%. The table below summarizes its recorded NADAC range and movement.

Current price$6.4442 per EA
All-time high$6.6829 (Aug 12, 2026)
All-time low$4.0723 (Nov 20, 2024)
52-week high$6.6829
52-week low$5.5853
Median price$5.7020
Average price$5.6595
Largest weekly change-29.1% (Nov 20, 2024)
Weeks tracked124
Tracking sinceApr 10, 2024

Price History

1W

-3.6%

1M

-3.6%

3M

+4.1%

6M

+13.1%

1Y

+13.6%

3Y

N/A

5Y

N/A

All

+23.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CARVEDILOL PHOSPHATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CARVEDILOL ER 40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL ER 40 MG CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $6.4442 per EA (NDC 00115125008), effective Aug 19, 2026.

How has the price of CARVEDILOL ER 40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CARVEDILOL ER 40 MG CAPSULE has risen 23.5%. It has been tracked across 124 weekly CMS publications since Apr 10, 2024.

What are the highest and lowest recorded NADAC prices for CARVEDILOL ER 40 MG CAPSULE?

Since Apr 10, 2024, the NADAC for CARVEDILOL ER 40 MG CAPSULE has ranged from a low of $4.0723 (Nov 20, 2024) to a high of $6.6829 (Aug 12, 2026), with a median of $5.7020 per EA.

Are there cheaper alternatives to CARVEDILOL ER 40 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of CARVEDILOL ER 40 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CARVEDILOL ER 40 MG CAPSULE?

CARVEDILOL ER 40 MG CAPSULE (NDC 00115125008) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.